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H3N8Inﬂuenza virus, subtype H3N8, was transmitted from horses to greyhound dogs in 2004 and subsequently
spread to pet dog populations. The co-circulation of H3N8 viruses in dogs and horses makes bi-directional
virus transmission between these animal species possible. To understand the dynamics of viral transmission,
we performed virologic surveillance in dogs and horses between 2005 and 2008 in the United States. The
genomes of inﬂuenza A H3N8 viruses isolated from 36 dogs and horses were sequenced to determine their
origin and evolution. Phylogenetic analyses revealed that H3N8 inﬂuenza viruses from horses and dogs were
monophyletic and distinct. There was no evidence of canine inﬂuenza virus infection in horses with
respiratory disease or new introductions of equine inﬂuenza viruses into dogs in the United States. Analysis
of a limited number of equine inﬂuenza viruses suggested substantial separation in the transmission of
viruses causing clinically apparent inﬂuenza in dogs and horses.d at Animal Health Diagnostic
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Equine inﬂuenza virus (EIV) subtype H3N8, emerged in Miami
(Florida, USA) in 1963 (Waddell et al., 1963) and subsequently spread to
equine populations around theworld (Barbic et al., 2009; Burrows et al.,
1981;Damiani et al., 2008; Ito et al., 2008; Newton et al., 2006; Thomson
et al., 1977; vanMaanen and Cullinane, 2002). The global spread of this
virus was temporally correlated with a sustained decline in the
prevalence of the previously dominant H7N7 subtype, which is now
considered extinct (Webster, 1993). Early studies indicated that equine
H3N8 viruses did not cause acute respiratory disease in other species,
including man (Kasel et al., 1965). However, in 2004, an H3N8 virus of
equine origin caused outbreaks of respiratory disease in dogs and spread
among several urban canine populations of the United States (Crawford
et al., 2005; Payungporn et al., 2008). Subsequent co-circulation ofH3N8
inﬂuenza viruses in horses and dogs created the opportunity for further
bi-directional interspecies transmission of inﬂuenza viruses between
these animal species (Crawford et al., 2005; Parrish and Kawaoka, 2005;
Payungporn et al., 2008). Experimentally, canine inﬂuenza viruses (CIV)
can replicate in the airway of horses (Yamanaka et al., 2010) whereas
horses infected with EIV can transmit the infection to contact dogs(Yamanaka et al., 2009). Molecular phylogenies of inﬂuenza viruses
isolated from these two species since 2004 can help us understand their
transmission dynamics and evolution in the natural environment. To
this end,we have analyzed the genomic sequences of 36 viruses isolated
from dogs and horses between 2005 and 2008 during passive virologic
surveillance in four major geographic regions of the United States.
Phylogenetic analysis of full genomes from CIV isolated since 2005
indicated that these viruses have evolved as a monophyletic group
rooted in equine inﬂuenza genes fromearlier times. Similarly, analysis of
EIV isolated in the same period (2005–2008) indicated that all their
genes belong exclusively to the equine Florida clade 1 (reviewed in
(Bryant et al., 2009). These evolutionary patterns indicate that the
interspecies transmission of equine inﬂuenza into dogs in 2003–2004
led to the emergence of a distinct inﬂuenza virus clade that causes a
transmissible respiratory disease in dogs. Conversely, despite the limited
number of EIV analyzed, these ﬁndings suggest that inﬂuenza-like
respiratory disease in horses associated with H3N8 viruses is predom-
inantly caused by equine virus lineages. These studies expand our
understanding of inﬂuenza virus ecology in mammals and provide a
foundation for further analysis of host range andvirulencedeterminants.
Results
Isolation of subtype H3N8 inﬂuenza viruses from dogs and horses with
respiratory disease
CIV isolates were obtained in both MDCK cells and in embryo-
nated eggs from samples that were determined to contain inﬂuenza
72 P. Rivailler et al. / Virology 408 (2010) 71–79virus by RT-PCR. In not all instances were both isolation procedures
successful and neither procedure was better than the other in all
cases. This was equally true for inﬂuenza virus isolates from equine
samples. Overall, isolates were obtained from RT-PCR positive
samples with Ct values less than 35 in more than 75% of the cases,
and for CT values between 35 and 40, the isolation rate was
approximately 50%. Most clinical samples submitted were swabs and
isolations from swabs simply moistened with saline were easily
obtained. In egg inoculations, samples had to be blind passed at least
once before considering the sample as negative due to the relatively
poor growth of mammalian H3N8 subtype viruses in eggs. Five
specimens yielded isolates from both MDCK and egg inoculations.
Approximately 50% of the isolations that were negative on MDCK
cells were positive with egg isolation.
Multiple isolates were obtained from some outbreaks and
representative samples were subjected to sequencing. The 29 canine
inﬂuenza A viruses shown in Table 1 were isolated from specimens
collected from 6 states representing 3 major geographic regions of the
United States. The largest number of isolates (13) originated from the
state of New York. Only 4 isolates originated from racing dogs, the
remaining isolates were from specimens collected from pet dogs.
Inﬂuenza A isolates were obtained from dogs ranging from 4 months
to 11 years of age. The specimens from which seven equine viruses
were isolated were collected from 5 different states representing all 4
major geographic regions of the US: Northeast (New York), Midwest
(Ohio), South-Central (Virginia) and South-Western (Texas) States
(Table 1).Table 1
Inﬂuenza viruses isolated from dogs and horses between 2005 and 2008, USA.
Virus isolate a Host
Strain name Date of collection Passage Breed
A/canine/NewYork/115809/2005 30-Sep-05 E2 Labra
A/canine/NewYork/4986-2/2006 16-Jan-06 C4 Fox t
A/canine/NewYork/5183-6/2006 16-Jan-06 C2; E1 Pit bu
A/canine/Colorado/8880/2006 25-Jan-06 C2 Deerh
A/canine/Colorado/17864/2006 17-Feb-06 C2; E1 Terrie
A/canine/Colorado/30604/2006 20-Mar-06 C2 Labra
A/canine/Florida/61156-2/2006 15-May-06 C2; E2 NA
A/canine/California/70645-4/2006 6-Jun-06 E2 Golde
A/canine/Florida/78592-2/2006b 20-Jun-06 E1 Greyh
A/canine/Florida/78592-6/2006b 20-Jun-06 C2 Greyh
A/canine/Florida/78592-7/2006b 20-Jun-06 E2 Greyh
A/canine/Florida/89911-2/2006 20-Jul-06 E1 Labra
A/canine/NewYork/100525-1/2006 16-Aug-06 C1 NA
A/canine/NewYork/100528-1/2006 16-Aug-06 C1 NA
A/canine/NewYork/100528-5/2006 16-Aug-06 C1 NA
A/canine/NewYork/100528-6/2006 16-Aug-06 C1 NA
A/canine/Kentucky/118778/2006 20-Oct-06 E1 Houn
A/canine/NewYork/147926-3/2006 18-Dec-06 C1 Mix
A/canine/NewYork/147926-5/2006 18-Dec-06 C2 Rottw
A/canine/Pennsylvania/10909/2007 30-Jan-07 E2 Mix
A/canine/Pennsylvania/10915/2007 30-Jan-07 E1 NA
A/canine/Pennsylvania/16699/2007 15-Feb-07 C1 Germ
A/canine/Pennsylvania/94930-3/2007 21-Jul-07 E2 Labra
A/canine/NewYork/115719/2007 7-Sep-07 E1 NA
A/canine/Colorado/6723-8/2008 17-Jan-08 E1; E2 NA
A/canine/NewYork/51854/2008 24-Apr-08 E1 Pitbu
A/canine/Pennsylvania/137154/2008 28-Oct-08 C3 Mix
A/canine/NewYork/145353/2008 18-Nov-08 C1 NA
A/canine/NewYork/158402-1/2008 31-Dec-08 C2 NA
A/equine/Texas/117793/2005 6-Oct-05 C3; E2 Quart
A/equine/Virginia/131054-3/2005 8-Nov-05 E2 NA
A/equine/Ohio/113461-1/2005 2005 E2 Quart
A/equine/Ohio/113461-2/2005 2005 C2; E2 Quart
A/equine/Ohio/113461-3/2005 2005 E2 Quart
A/equine/NewYork/146066/2007 26-Sep-07 E2 NA
A/equine/Montana/9233/2007 16-Nov-07 C3 Quart
a NA: not available; m: month; yr: year; M: male; F: female; N: neutered; S: spayed.
b Fatal case.Evolution of canine and equine inﬂuenza viruses from 2005 to 2008
To investigate the transmission dynamics of H3N8 inﬂuenza
viruses in horses and dogs after the emergence of canine inﬂuenza
virus (CIV) in 2004, we characterized inﬂuenza A viruses isolated from
these species in the United States between 2005 and 2008 (Table 1).
Nucleotide sequence analysis of 36 inﬂuenza A viruses that were
isolated from dogs and horses revealed the absence of nucleotide
deletions or insertions in any of the eight viral gene segments. The
phylogenetic relationships of the eight genes of viruses isolated from
dogs and horses indicated that they evolved into two distinct clades in
each of these animal hosts (Figs. 1 and 2, red and yellow shading)
diverging from ancestor viruses circulating around 2002–2003.
Six of the canine inﬂuenza genes (HA, NA, PB2, PB1, PA, and NP)
formed distinct clades statistically supported by bootstrap values
exceeding 90% (Figs. 1 and 2, red shading) whereas the M and NS
genes were less divergent, with bootstrap values of 36% and 66%,
respectively (Figs. 2E and F, red shading). This was expected because
M and NS encode for essential viral proteins in different but
overlapping reading frames, greatly reducing the probability of
synonymous mutations in the dually coding region and thus
constraining divergence (Ito et al., 1991; Kawaoka et al., 1998).
However, a subset of more divergent M and NS genes evolved with
bootstrap support above 90% (Figs. 2E and F).
The phylogenetic trees revealed that all genes of A/canine/
Florida/242/03 and A/canine/Florida/43/04 are closely related to
contemporary equine viral genes as evidenced by their position on theAge Sex Housing
dor 10 yr M Veterinary hospital
errier 18 m MN Animal shelter
ll 12 m M Animal shelter
ound 10 m MN Stray from Humane Society
r mix 6 m SF Adopted from rescue
dor 11 yr MN Boarded at positive CIV kennel
NA NA Animal shelter
n retriever 2 yr M Training kennel
ound NA NA Racing
ound NA NA Racing
ound NA NA Racing
dor NA NA Shelter dog
NA NA Animal shelter
NA NA Animal shelter
NA NA Animal shelter
NA NA Animal shelter
dX 4 m F Humane Society
10 m NA Animal shelter
eiler 3 yr NA Animal shelter
6 m M Pet
6 m F Pet
an shepherd Humane Society
dor 3 yr F Pet
NA MN Pet
NA NA Kenneled dog from Lee County
ll 2 yr M Animal shelter
2 yr M Pet
NA NA Animal shelter
6 yr M Animal shelter
er horse 1 yr NA Pet
3 yr F Equine clinic
er horse 2 yr M University equine stable
er horse 2 yr M University equine stable
er horse 2 yr M University equine stable
NA NA Equine farm
er horse 18 yr F Equine training school
Fig. 1. Evolution of the CIV genome: phylogenetic analysis of H3 hemagglutinin (HA) and N8 neuraminidase (NA) genes. Phylogenetic analysis of CIV and EIV HA (panel A) and NA
(panel B) genes representative of a total of 36 viral genomes sequenced in this project (accession numbers shown in Supplementary Table 1). The phylogenetic tree was constructed
by Neighbor-Joining using MEGA software (Kumar et al., 2004) and includes selected EIV H3N8 collected after 1989 as well as CIV sequences. The trees were rooted to A/equine/
Miami/1/1963. The reliability of the phylogeny was assessed with 1000 bootstrap replicates. Values greater than 90% are indicated at the node of the branches. Sequences from this
project are indicated with an asterisk (*). The horizontal bar denotes the unit scale of nucleotide substitutions per site for the tree branch lengths. Genes from emerging CIV isolated
in 2003–2004 are shown in blue shading, whereas those of enzootic CIV isolated after 2005 are indicated in red shading. EIV isolated in 2005–2207 are indicated in yellow shading.
EIV genes most closely related to those of emerging CIVs are indicated with a red arrowhead.
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divergence from the equine genes also suggested that theymay be the
earliest known H3N8 viruses adapted to horizontal transmission in
dogs; thus, referred to as “emerging CIV” in this communication
(Crawford et al., 2005; Payungporn et al., 2008). The EIV isolates most
closely related to these emerging CIV can be readily identiﬁed in each
of these trees andmay represent the nearest equine viruses sharing an
immediate ancestor with them, namely, A/equine/Kentucky/9/2004
(for HA), A/equine/Ohio/1/03 (for NA, PB2), A/equine/Wisconsin/
1/03 (for PB1, NP), A/equine/California/8560/02 (for PA and NS), A/
equine/California/4537/97 (for M) (Figs. 1 and 2; red arrowhead).
One or more EIV with a similar genotype circulating in 2002–2003
would be a likely candidate ancestor of the emerging A/canine/
Florida/242/03 and/or A/canine/Florida/43/04 viruses.
Phylogenetic analysis of seven EIV isolated between 2005 and
2008 from four major geographic regions of the United States
indicated that all genes diverged from the equine viruses of previous
years (Figs. 1 and 2, yellow shading). These clades have lowerbootstrap support than the contemporary canine virus clades but are
deﬁnitely distinct from earlier viruses. In contrast, the genes of some
recent equine viruses from Asia (e.g. A/equine/Hubei/6/2008; A/
equine/Xinjiang/1/2007, Fig. 1) formed a distinctive clade branching
away from viruses from North America, Asia, Africa and Oceania
(Figs. 1 and 2).
A comparative analysis of tree topologies from each of the CIV and
EIV genes in the context of a broad range of previously reported
inﬂuenza viruses adapted to other species indicated that all CIV and
EIV genes have co-evolved independently; i.e. no evidence of genetic
reassortment was found (Figs. 1 and 2 and Supplementary Fig. 1).
Further studies will be necessary to identify the underlying ecological
or virological determinants of their evolution.
The consistent monophyletic evolution of the CIV isolated from
dogs between 2005 and 2008 (Figs. 1 and 2, red) contrasts with the
graded evolution of the emerging canine viruses (Figs. 1 and 2, blue)
as indicated by their proximity to contemporary equine viruses. This
evolutionary distance could also be attributed to temporal
Fig. 2. Evolution of the CIV genome; phylogenetic analysis of PB2, PB1, PA, NP, M, and NS genes. Phylogenetic analysis of CIV and EIV PB2, PB1, PA, NP, M and NS genes (Panels A
through F, respectively) representative of a total of 36 viral genomes sequenced in this project (accession numbers shown in Supplementary Table 1). Annotation conventions are as
in Fig. 1. Bootstrap values less than 90% are indicated in parenthesis at the node of equine and canine branches. ca: canine; eq: equine.
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insufﬁcient sampling. In addition, the ecological separation between
the racing greyhound populations that apparently supported the
emerging CIV and the subsequent circulation of CIV in boarding
kennels and pet dog shelters could be a contributing factor. The
continued circulation of CIV in certain canine populations since 2005
indicates that the virus has become enzootic in dogs at these locations.
Therefore, we refer to the 2005–2008 CIV clade as “enzootic CIV” to
distinguish it from the “emerging CIV” viruses from 2003 to 2004
(Figs. 1 and 2, red shading).
None of the genes of viruses isolated recently from horses had the
genomic sequence signatures from the 2005 to 2008 CIV clade
(Payungporn et al., 2008), suggesting that H3N8 viruses from thecanine inﬂuenza virus clade are not a leading cause of respiratory
disease in US horses (Figs. 1 and 2). Taken together, the eight gene
phylogenies showed that the divergent evolution of canine and
equine inﬂuenza virus genes since 2004 is consistent with separate
chains of virus transmission responsible for acute respiratory disease
in the respective equine and canine host populations.
Evolution of the CIV and EIV proteomes
Previous studies identiﬁed a set of 6 amino acid substitutions in
the HA protein of emerging canine inﬂuenza viruses, thought to be
associated with the host switch event (Crawford et al., 2005;
Payungporn et al., 2008). To characterize the subsequent evolution
Table 2
Evolution of the CIV proteome.
a For HA, amino acid numbering is that of the human H3 hemagglutinin; e.g. A/Aichi/2/68, GenBank accession no. AAA43178.
b Amino acid residues found in all H3N8 EIVs collected between 1990 and 2003. Variations to consensus are indicated in footnotes.
c One isolate has an asparagine at position 27 (A/equine/California/4537/1997).
d Seven isolates (2896 analyzed sequences; 0.2%) have a serine at position 83 (A/equine/Newmarket/1/1993; A/equine/Grobois/1/98; A/equine/Brescia/1999; A/equine/
Cheltenham/1/01; A/equine/Lincolnshire/1/2002; A/equine/Pulawy/1/2005; A/equine/Aboyne/1/05).
e One isolate has a serine at position 118 (A/equine/Newmarket/1/1993).
f Four isolates (2893 analyzed sequences; 0.1%) have a leucine at position 222 (A/Equine/Alaska/1/91; A/equine/Alaska/29759/1991; A/equine/Rome/5/91; A/equine/
Qinghai/1/1994).
g Forty-two isolates (1.4%) have an arginine and 3 isolates (0.1%) have a glycine at position 261.
h One isolate has a lysine at position 483 (A/equine/Guelph/G03-0250/2003).
i Two isolates (4%; [A/Equine/Alaska/1/91; A/equine/Alaska/29759/1991]) have a methionine at position 147.
j Amino acid residues in emerging CIVs (A/canine/Florida/242/2003 and A/canine Florida/43/2004).
k Blue-shaded boxes denote novel amino acid substitution in “emerging H3N8 CIV” viruses.
l Amino acid residues found in enzootic H3N8 CIV sequences (absent in Florida isolates from 2003 to 2004).
m Green-shaded boxes denote novel amino acid substitution in enzootic H3N8 CIV.
n One isolate has a valine at position 374.
o One isolate has a mixed base isoleucine/methionine at position 29.
75P. Rivailler et al. / Virology 408 (2010) 71–79of canine inﬂuenza virus proteomes relative to EIV sequences, we
compared the amino acid sequences of the 11 viral proteins
(Supplementary Table 2) from all the new viruses identiﬁed in the
course of this study. The multiple amino acid sequence alignment
conﬁrmed the 6 previously reported amino acids in HA that
characterized the emerging CIV as distinct from the EIV ancestors
(Crawford et al., 2005; Payungporn et al., 2008). The whole
proteome analysis identiﬁed 4 additional changes in emerging CIV:
1 in PB2 (L374I), 2 in PA (D27N, N675D) and 1 in NP (D375N). The
latter substitution is found only in one of the two emerging CIV
isolates (Table 2 and Supplementary Table 3). Interestingly, none of
the 10 changes identiﬁed in the proteomes of emerging CIV reverted
to the EIV-like amino acid residues in subsequent years (Table 2,
Supplementary Table 2). All the enzootic CIVs share a total of 9 new
amino acid substitutions as compared to the emerging CIVs (Table 2
and Supplementary Table 3). These substitutions were not evenly
distributed throughout the proteome; changes were more frequent
in PB2 and HA than in other proteins. Three shared substitutions
occurred in PB2; S107N, A221V and I292T, and 3 in HA; L118V,
K261N, and G479E (using the human H3 HA amino acid position
numbering system, per Table 2) (Payungporn et al., 2008). The 3
remaining substitutions were observed in NA (I62L, V147I) and PB1
(V200I). In addition, two sites with polymorphic residues selected
for a single residue were identiﬁed: I/M29M in HA and D/N375N in
NA (Table 2). The amino acid substitutions in virion surface proteins
and two polymerase complex subunits are likely to carry functional
signiﬁcance as they are most frequently associated with host range
and virulence (Neumann and Kawaoka, 2006). Their potential rolesTable 3
Evolution of the EIV proteome.
Protein PB2 PB1
Position 398 411 660 94 621
EIV (1990–2004) I I K F K
EIV (USA, 2005–2007) V V b R c L R
CIV I I K F K
a The stop codon ﬁrst detected in 2002 in the NS1 coding region results deletion of the P
b One isolate has isoleucine at position 411 (A/Equine/NewYork/146066/07).
c One isolate has a mixed base encoding lysine/arginine at position 660 (A/Equine/Ohioin virus-host interactions favoring viral adaptation to the new canine
host merit further study.
The proteomes of EIV isolated between 2005 and 2007 revealed
considerable evolution relative to their immediate ancestors. A total of
10 substitutions were identiﬁed in the proteomes of 2005–2007 EIVs
compared to those of progenitor viruses circulating up to 2003 in the
USA. With the exception of HA, NP, M and NS2, all viral proteins
acquired amino acid substitutions. The polymerase genes featured a
large number of substitutions, as follows PB2 I398V, I411V, and
K660R; PB1 F94L, and K621R; PB1-F2 S63Y, and PA I465V. The NA
protein acquired two substitutions; I8M and V35A. The M2 protein
showed a single amino acid change; L59M. Interestingly, the 10 amino
acid changes that characterized the 2005–2007 EIV are not found in
emerging and enzootic CIV. Notably, a stop codon introduced at
position 220 in NS1 from EIV of the so-called “American lineage” was
stably maintained in all the EIV analyzed in this study (Table 3).
Although these ﬁndings are consistent with the continued divergent
evolution of the EIV clade in the USA, the absence of “ﬁxed”
substitutions in HA was unexpected.
Discussion
The presence of canine inﬂuenza virus (CIV) in the companion
animal population was not identiﬁed until the summer of 2005 with
the isolation of CIV from several pet dogs in Florida and the
identiﬁcation of CIV in the New York City area (Dubovi and Njaa,
2008). The movement of CIV in dogs was tracked by the isolation of
virus from clinical cases and by the detection of antibodies to CIV inPB1-F2 PA N8 M2 NS1
63 465 8 35 59 220
S I I V L R/STOP a
Y V M A M STOP
S I I V L R
DZ domain.
/113461-2/05).
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attempts were made to obtain clinical samples from contact animals
for isolation of the virus. The movement of CIV in the companion
animal population was unpredictable and sporadic. By the end of
2006, there were at least three enzootic areas in the US—Florida,
Colorado, and the New York City area which included northern New
Jersey and Connecticut. Movement of infected dogs from these areas
initiated local outbreaks of infection in California, Wyoming, Ken-
tucky, Delaware and western Pennsylvania. In each instance, there
was no evidence that the virus was maintained in the new locations.
By the end of 2008, the enzootic area on the East coast had extended
into eastern Pennsylvania. The geographic separation of the enzootic
areas do present the possibility for CIV to evolve somewhat
independently in each of these regions. Future surveillance in dogs
might reveal spatially deﬁned CIV lineages.
Both cell culture and egg inoculation were successful in isolating
CIV and EIV, and in parallel testing neither test system proved
superior to the other (data not shown). The most critical factor in
isolating inﬂuenza viruseswas early collection of clinical samples after
onset of clinical signs. In experimental infections, the peak of virus
shedding is 2–4 days post infection (Deshpande et al., 2009). By day 7
post infection an HI antibody response is detectable and infectious
virus is absent from the respiratory tract. A positive PCR signal can
be obtained for several days longer, but by 7 days after the onset of
clinical signs, all virus culture tests will be of questionable value.
The frequent isolation of CIV from dogs with respiratory disease
between 2005 and 2008, suggested its sustained circulation in the
United States for at least 5 years since its emergence. However, a
complete molecular analysis of viral isolates was necessary to
determine whether these inﬂuenza isolates originated from dogs
infected with emerging CIV, or multiple independent events of EIV
transmission to dogs, which has been detected in nature and
experimentally (Daly et al., 2008; Kirkland et al., 2010; Yamanaka
et al., 2009). Our results show that CIV isolated from dogs with acute
respiratory disease between 2005 and 2008 have evolved as a distinct
monophyletic lineage, rooted in the emerging CIV from 2003 to 2004
and closely related EIV. The absence of equine H3N8 viruses in the CIV
lineage suggests that transmission of EIV to dogs was not a major
cause of acute respiratory disease in the canine populations included
in this surveillance. Conversely, despite the limited number of EIV
analyzed, H3N8 viruses isolated from horses are exclusively from the
recent EIV clade, suggesting that CIV are not being transmitted back to
horses. This ﬁnding is consistent with the inefﬁcient replication of CIV
in horses reported recently (Yamanaka et al., 2010). Taken together,
these ﬁndings indicate that barring the existence of an unknown
animal reservoir, CIV has been maintained by horizontal transmission
in the canine population of the United States for at least 5 years.
The divergence of CIV genes revealed by nucleotide sequence
phylogenies entailed multiple non-synonymous mutations that
characterized the evolution of the viral proteomes. Nineteen amino
acid codons that were highly conserved in the previous decade of
EIV H3N8 evolution were mutated in the enzootic CIV proteins
(Table 2). The PB2 and HA proteins showed the greatest number of
changes. Evolution of the contemporary CIV PB2 included multiple
substitutions relative to the EIV ancestors; S107N, A221V and I374V.
The former two changes map to PB2 domains of unknown function,
whereas the last are located in regions mediating cap binding or
close to the mRNA cap binding site (Guilligay et al., 2008),
suggesting that these substitutions may be involved in optimizing
essential interactions of the viral polymerase complex with canine
host factors in the nuclear environment. Previous studies have
shown that glutamic acid to lysine changes at position 627 (E627K)
of PB2 are important for replication of avian inﬂuenza viruses in
mammalian hosts (Hatta et al., 2001). Glutamic acid 627 (627E) has
been highly conserved in the PB2 of equine viruses since their
introduction from birds into horses in 1963 (Shinya et al., 2007).Interspecies transmission of EIV into dogs in 2003–2004 did not
depend on substitution E627K, and this residue remains unchanged
after 5 year of CIV circulation in the canine population. Lack of
positive selection for PB2 627 K in equine and canine species
suggests that host factors from these two species interact most
favorably with glutamic acid at residue 627 to support the efﬁcient
replication of these virus groups. However, it is likely that preference
for E or K residues at position 627 is context-dependent; i.e. other
polymerase complex gene lineages may have other structure-
function properties (Bussey et al., 2010; Coloma et al., 2009; Hatta
et al., 2001; Kuzuhara et al., 2009; Massin et al., 2001; Naffakh et al.,
2000; Shinya et al., 2004).
Previous sequence analysis of the HA from emerging CIV identiﬁed
ﬁve amino acid substitutions at invariant or highly conserved
positions of the EIV HA; N54K, N83S, W222L, I328T, N483T (Crawford
d et al., 2005; Payungporn et al., 2008). The substitution of tryptophan
at position 222 (W222) of the HA with leucine (W222L) provides the
most compelling association with host switch events. All sequenced
HA from EIV reveals tryptophan at position 222, except A/equine/
Qinghai/1/1994 and A/equine/Alaska/29759/1991, in which it was
replaced with leucine as well. Interestingly, the W222L substitution
present in all the CIV was also temporally correlated with the
transmission of avian inﬂuenza viruses H3N2 to dogs in Korea (Song
et al., 2008) as well as the recent transmission of EIV H3N8 to swine in
China (Tu et al., 2009). TheW222L substitution may alter the receptor
binding functions that mediate favorable interactions with host
factors for virus transmission between dogs. For example, Meisner
et al. (2008) reported that an H3N2 human virus with a Y98F
substitution in the receptor binding site is highly attenuated for mice
but a compensatory W222R substitution restored virulence and
receptor binding functions. Finally, a recent report suggested
inefﬁcient binding of CIV to N-glycolyl neuraminic acid glycans as
compared to EIV, suggesting a possible involvement of W222L in host
range functions (Yamanaka et al., 2010). The I328T substitution is
adjacent to the R at the cleavage of the HA precursor molecule HA0
(sequence: PEKQTR↓GIFGAI; T underlined, arrow at cleavage site),
which is required to activate virus infectivity (Klenk et al., 1975).
Replacement of a hydrophobic isoleucinewith a polar threonine in the
HAs of CIV may optimize extracellular cleavage of HA0 in the canine
airway. Interestingly, the EIV transmitted to swine in China (e.g. A/
swine/Anhui/01/2006), also acquired this substitution relative to
contemporary equine viruses (Tu et al., 2009). The functional
signiﬁcance of other substitutions at positions 54, 83, and 483 in the
mature HA also highly conserved in equine viruses remains unknown.
The enzootic CIV HA clade also acquired L118V and K261N
substitutions as compared to the emerging CIV. These changes are
located near or within known antigenic sites of the human H3 HA
trimer, and may represent early antigenic drift events. Compared to
human inﬂuenza viruses (H3N2), the CIV HA evolved at a consider-
ably lower rate (~1.8 aa per year) since its emergence in dogs (Bean
et al., 1992). However, it evolved at a faster rate than the EIV
counterpart (Lai et al., 2001), as it might be expected for a virus
following a host switch event (Parrish and Kawaoka, 2005). Therefore,
it is anticipated that the newly developed canine inﬂuenza vaccines
will not require the frequent antigen composition update typical of
human inﬂuenza vaccines (Wood, 2002).
Although the laboratory hosts used for the isolation of inﬂuenza
viruses are known to often mediate selection of variant viruses with
mutations in the HA (Bush et al., 1999; Katz et al., 1987; Robertson
et al., 1995; Rogers et al., 1985), there was no correlation between the
laboratory host for virus isolation and amino acid substitutions in the
HA from this study, suggesting that this is not a likely source of the
observed mutations (Table 2 and Supplementary Table 2).
Other changes in the proteome of enzootic CIV were noted in PB1
(V200I), and NA I62L. Although these residues were highly conserved
among EIV sequences (Supplementary Table 2), the role of these
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similarity between these hydrophobic amino acids (Ruigrok et al.,
2010). No novel changes were noted among the proteins encoded by
NP, M and NS genes of enzootic CIV.
We also examined the evolution of the proteome of EIV in the
decade before the emergence of CIV for clues regarding changes in
proteins involved in host interactions. The most remarkable change
was found in the NS1 protein. EIVs isolated after 2002 contain
truncated NS1, with a premature termination codon at position 220
(Bryant et al., 2009). This deletion resulted in the loss of a PDZ
domain, a widely distributed protein motif that mediates protein–
protein interactions in cell signaling and modulates inﬂuenza virus
replication (Jackson et al., 2008; Jemth and Gianni, 2007). However,
the EIV ancestor of CIV had a full-length NS1, and all CIV NS1 proteins
retained the PDZ domain. Further studies on the importance of NS1
PDZ domain of EIV for infection and sustained transmission in dogs
would shed light on this topic (Kirkland et al., 2010; Yamanaka et al.,
2009; Yamanaka et al., 2008) (Supplementary Table 4).
Sustained transmission of CIV (H3N8) in dogs was reported only in
the United States (Dubovi and Njaa, 2008; Payungporn et al., 2008)
whereas EIV (H3N8) outbreaks have been reported globally after its
emergence in horses decades ago. The apparent limited global spread
of CIV contrasts with the global distribution of other viral respiratory
diseases of dogs. It has been suggested that CIV is not as transmissible
as other inﬂuenza viruses (Dubovi and Njaa, 2008). However, global
surveillance for CIV infections in dogs is incomplete and further
studies are needed to better understand the geographic distribution of
this virus. In addition, ongoing virologic surveillance programs for EIV
should identify cases of respiratory disease in horses caused by CIV, if
they were to occur in signiﬁcant numbers.
Natural infection of dogswith the 2009 pandemic H1N1 virus were
reported by the news media (AVMA, 2009) suggesting that reassort-
ment between the human pandemic virus and H3N8 CIV could
theoretically occur in co-infected dogs. Dogs were also reported to be
susceptible to infection with human H3N2 inﬂuenza viruses (Rom-
omvary et al., 1975). Although the probability of co-infection between
human inﬂuenza viruses and CIV seems low due to the restricted
circulation of the latter to dog shelters, and boarding kennels housing
many animals, virologic surveillance and molecular analysis of
circulating isolates from canine species is essential for early detection
of emerging reassortment.
Our passive virologic surveillance based on acute respiratory
disease indicated that CIV were isolated exclusively from dogs and
equine viruses from horses. Several factors could account for the
linkage of these viruses to the homologous species. First, interspecies
transmission does not occur due to the limited contact between the
urban canine population in which CIV circulates and the rural equine
population. Second, interspecies transmission of canine and EIV does
occur, but fails to cause clinically apparent disease or its incidence is
below the detection threshold of this study. Third, interspecies
transmission does not occur due to viral dependence on a mutually
exclusive species-speciﬁc function. Further studies are needed to
determine the circulation dynamics of H3N8 inﬂuenza viruses in
canine and equine hosts. However, these ﬁndings provide a rationale
to postulate that H3N8 EIV circulating in horses do not easily infect
canines and spread widely in this species and vice versa. In general, it
would be important to determine whether interspecies transmission
of H3N8 inﬂuenza viruses has a ﬁtness cost that prevents these
viruses from circulating in dogs and horses indiscriminately.
Materials and methods
Virologic surveillance and virus isolation
With the identiﬁcation of inﬂuenza virus associated with
respiratory disease in dogs in early 2004, the Animal HealthDiagnostic Center at Cornell initiated an enhanced testing program
on respiratory samples from dogs that were submitted by referring
veterinarians. Most of the specimens received were nasal swabs,
either cotton or Dacron, or an occasional tissue sample from
necropsy. In addition to routine virus isolation attempts for standard
respiratory viruses of dogs, samples were also subjected to real-time
reverse transcriptase PCR assay for inﬂuenza virus targeting the
matrix gene (Spackman et al., 2002). This assay that was being used
for avian inﬂuenza virus surveillance programs detected all canine
and equine inﬂuenza viruses tested. The standard protocol for canine
and equine samples was to perform the RT-PCR assay and those
samples with Ct values of b40 were processed for inﬂuenza virus
isolation. Screening of equine respiratory samples for inﬂuenza virus
using the same strategy had been ongoing prior to the initiation of
testing in canines.
Inﬂuenza viruses were isolated by two methods; cell culture
isolation and/or embryonated chicken eggs. For tissue culture
isolation, MDCK cells were inoculated with the test sample
followed by incubation at 37 °C in medium containing 0.3% BSA
plus 2 μg/ml of acetylated trypsin (Sigma). Culture supernatants
were tested for the presence of inﬂuenza virus by either
hemagglutination (HA) assay, RT-PCR, or antigen-capture ELISA
tests. For egg isolations, 10-day-old speciﬁc pathogen-free (SPF)
embryonated eggs were inoculated in the allantoic cavity with 0.1–
0.2 ml of clinical sample. Eggs were incubated for 4 days and the
allantoic ﬂuid collected. Presence of inﬂuenza virus was deter-
mined by HA assay. Negative samples were re-inoculated into eggs
for a second passage. HA negative samples from the second
passage were considered negative for inﬂuenza virus. In many
instances, if one of the isolation systems yielded a positive result,
the other was not attempted.
Sequence analysis
RNA isolation and sequencing procedures were described previ-
ously (Crawford et al., 2005; Payungporn et al., 2008). Brieﬂy, viral
RNA was extracted from infectious allantoic ﬂuid or cell culture
supernatants with the Qiagen RNeasy extraction kit, and a one-step
RT-PCR kit (Qiagen) was used to transcribe and amplify genomic
segments as DNA fragments. DNA amplicons spanning the complete
open reading frame(s) of viral genes were sequenced on an
automated Applied Biosystems 3730 system using cycle sequencing
dye terminator chemistry (Perkin-Elmer, Foster City, CA). Primer
sequences are available upon request. Contiguous sequences were
generated with Sequencher 4.9 software (Gene Codes). The overall
sequence coverage was estimated at 4.3-fold. Gene sequences
generated in this study were submitted to the GenBank database
(Supplementary Table 1).
Phylogenetic analysis
Our analysis data set included inﬂuenza gene sequences that
were downloaded from the NCBI Inﬂuenza Virus Resource (http://
www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html). Curated data sets
for each gene were aligned to newly generated project sequences
using MAFFT software (Katoh et al., 2002). Phylogenetic tree
inferences were generated by the MEGA software package (version
4) using the neighbor-joining method with a maximum composite
likelihood model (Kumar et al., 2004; Saitou and Nei, 1986).
Comprehensive phylogenetic trees including all new sequences
from this project in the context of other host-species adapted
lineages (avian, human, swine, and others) are shown in Supple-
mentary Fig. 1. Sequences belonging to the H3N8 equine lineage
were selected and re-aligned using MUSCLE software (Edgar, 2004)
to reduce errors. Multiple sequence alignments were edited
manually with BioEdit (http://www.mbio.ncsu.edu/BioEdit/
78 P. Rivailler et al. / Virology 408 (2010) 71–79bioedit.html) as needed. The reliability of phylogenetic inference at
each tree node was estimated by the bootstrap method with 1,000
replications, using the MEGA package (Efron and Tibshirani, 1994).
To enable visualization, a representative subset of newly sequenced
viruses selected on the basis of uniqueness in date of isolation,
geography and sequence divergence is shown in Figs. 1 and 2. The
complete set of new sequences analyzed in this study is shown in
Supplementary Table 1.
Supplementarymaterials related to this article can be found online
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